Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Elif Şenocak Taşçı
46  Ergebnisse:
Personensuche X
?
1

Real-World Efficacy and Safety of First-Line Nivolumab Plus..:

Kutlu, Yasin ; Dae, Shute Ailia ; Yilmaz, Feride...
Cancers.  16 (2024)  12 - p. 2251 , 2024
Link: https://doi.org/10.3390/..
 
?
2

Comparing the efficacy of regorafenib and 5-fluorouracil-ba..:

Taşçı, Elif Şenocak ; Oyan, Başak ; Sönmez, Özlem...
BMC Cancer.  24 (2024)  1 - p. , 2024
Link: https://doi.org/10.1186/..
 
?
3

Correction: Comparing the efficacy of regorafenib and 5-flu..:

Taşçı, Elif Şenocak ; Oyan, Başak ; Sönmez, Özlem...
BMC Cancer.  24 (2024)  1 - p. , 2024
Link: https://doi.org/10.1186/..
 
?
4

PROPSEA, safety evaluation of palbociclib and ribociclib in..:

Avcı, Okan ; İriağaç, Yakup ; Çavdar, Eyyüp...
Journal of Geriatric Oncology.  14 (2023)  8 - p. 101604 , 2023
Link: https://doi.org/10.1016/..
 
?
5

Coronaphobia: A barrier to ongoing cancer treatment?:

Sönmez, Özlem ; Tezcanli, Evrim ; Taşçı, Elif Şenocak...
Psycho-Oncology.  31 (2022)  7 - p. 1178-1185 , 2022
Link: https://doi.org/10.1002/..
 
?
6

The Relationship between the Sydney Classification and the ..:

Şenocak Taşçı, Elif ; Akbaş, Türkay
Medical Principles and Practice.  29 (2020)  6 - p. 551-557 , 2020
Link: https://doi.org/10.1159/..
 
?
7

Malignant pleural mesothelioma with rarely seen metastases:

Taşçı, Elif Şenocak ; Akın, Gül ; Öneç, Birgül.
Journal of Oncological Sciences.  3 (2017)  3 - p. 133-134 , 2017
Link: https://doi.org/10.1016/..
 
?
8

Comparing the efficacy of regorafenib and 5-fluorouracil-ba..:

Elif Şenocak Taşçı ; Başak Oyan ; Özlem Sönmez...
https://doi.org/10.1186/s12885-023-11783-5.  , 2024
Link: https://doi.org/10.1186/..
 
?
9

Intramural Component of Venous, Lymphatic, and Perineural I..:

Leyla Özer ; Elif Şenocak Taşçı ; Arda Ulaş Mutlu...
https://balkanmedicaljournal.org/text.php?lang=en&id=2447.  , 2022
Link: https://doi.org/10.4274/..
 
?
10

Malignant pleural mesothelioma with rarely seen metastases:

Elif Şenocak Taşçı ; Gül Akın ; Birgül Öneç.
http://www.sciencedirect.com/science/article/pii/S2452336417300560.  , 2017
Link: https://doi.org/10.1016/..
 
?
11

Correction: Comparing the efficacy of regorafenib and 5-flu..:

Taşçı, Elif Şenocak ; Oyan, Başak ; Sönmez, Özlem...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10804792/.  , 2024
Link: http://www.ncbi.nlm.nih...
 
?
12

Comparing the efficacy of regorafenib and 5-fluorouracil-ba..:

Taşçı, Elif Şenocak ; Oyan, Başak ; Sönmez, Özlem...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10763265/.  , 2024
Link: http://www.ncbi.nlm.nih...
 
?
13

Comparing the efficacy of regorafenib and 5-fluorouracil-ba..:

Şenocak Taşçı, Elif ; Oyan, Başak ; Sönmez, Özlem...
BMC Cancer.  , 2024
Link: https://hdl.handle.net/2..
 
?
14

Correction: Comparing the efficacy of regorafenib and 5-flu..:

Şenocak Taşçı, Elif ; Oyan, Başak ; Sönmez, Özlem...
BMC Cancer.  , 2024
Link: https://hdl.handle.net/2..
 
?
15

Comparing the efficacy of regorafenib and 5-fluorouracil-ba..:

Şenocak Taşçı, Elif ; Oyan, Başak ; Sönmez, Özlem...
BMC Cancer.  , 2024
Link: https://hdl.handle.net/2..
 
1-15